शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEPOLSON LTD.· Chemicals & PetrochemicalsHighNeutral
Announced Fri, 14 Aug, 2026 · 15:48 IST

Board approves Q1 FY27 results, re-appoints Independent Director

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.0%Reaction day
₹12121.00
prior close
₹12347.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-1.1% vs market
Specialty Chemicals peers, median of 94sector-0.6%-0.4% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
-1.5
15m
-1.1
30m
-1.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.0+0.1-1.1-0.6-0.4
Next day
-2.6+0.5-3.1-1.0-1.6
2d
-1.0-0.1-0.9-1.0-0.0
3d
—+0.4—-1.1—
4d
-1.0+0.7-1.7-0.9-0.1
5d
-1.0+0.9-2.0-1.1+0.1
1w
-5.5+1.1-6.6+0.2-5.7
15d
-9.9+1.6-11.5+0.7-10.6
1m
—-0.7—-1.1—
2m
-14.6-3.2-11.4-2.6-12.0
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 94Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

POLSON LTD board on Aug 14, 2026 approved unaudited standalone Q1 FY27 results for the quarter ended June 30, 2026. Revenue from operations rose to about Rs 28.32 crore vs Rs 23.93 crore YoY, around 18 percent growth. Profit after tax grew to about Rs 2.32 crore vs Rs 1.67 crore YoY, roughly 38 percent jump. Limited review report by R G B & Associates was clean with no qualifications. Board also re-appointed Mr Bhavin Suryakant Sheth as Independent Director for a second term of five years from June 30, 2026, subject to shareholder approval.

Likely market impact

Mixed: revenue growth under 20 percent but PAT up about 38 percent YoY; director re-appointment is routine.